M M Mata - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

M M Mata

Showing results (11-20 of 12) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 12 results.

Clinical Breast Cancer|March 22, 2026

Reduced Survival Outcomes in Socioeconomically Disadvantaged Women With HER2-Negative Breast Cancer Undergoing Chemotherapy in CanadaDanilo Giffoni M M Mata, Italo Fernandes, Megan Smith-Uffen, et al.

JTO Clinical and Research Reports|September 25, 2023

Programmed Cell Death Protein 1 Inhibitors and MET Targeted Therapies in NSCLC With <i>MET</i> Exon 14 Skipping Mutations: Efficacy and Toxicity as Sequential TherapiesSally C M Lau, Kirstin Perdrizet, Andrea S Fung, et al.

Pageof 2

Search research articles

Showing results (11-20 of 12) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 12 results.

Clinical Breast Cancer|March 22, 2026

Reduced Survival Outcomes in Socioeconomically Disadvantaged Women With HER2-Negative Breast Cancer Undergoing Chemotherapy in CanadaDanilo Giffoni M M Mata, Italo Fernandes, Megan Smith-Uffen, et al.

JTO Clinical and Research Reports|September 25, 2023

Programmed Cell Death Protein 1 Inhibitors and MET Targeted Therapies in NSCLC With <i>MET</i> Exon 14 Skipping Mutations: Efficacy and Toxicity as Sequential TherapiesSally C M Lau, Kirstin Perdrizet, Andrea S Fung, et al.

Pageof 2